Latest filing published 21 Feb 2008 for BRADLEY PHARMACEUTICALS INC, €192k.
Insider track record
No signal scores available.
Douglas Linton: trading record in brief
Douglas Linton discloses dealings in Bradley Pharmaceuticals Inc to SEC (Form 4). The record holds 2 filings, all for trades on 21 February 2008.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 21 February 2008, the filings show a transaction worth €202k in Bradley Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Douglas Linton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$18.96Common StockSEC:0000864268-08-000007:0
1 of 1 declaration